Evidence map›Paper›PMID 27051863›Full record

ArticleScience advances2016

Regulation of protein-ligand binding affinity by hydrogen bond pairing.

Deliang Chen, Numan Oezguen, Petri Urvil, Colin Ferguson, Sara M Dann, Tor C Savidge

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 326 papers.

0numbers the graph read from it
0cells of the map it votes in
326citing papers in PubMed
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

326 citing papers in PubMed, 879 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. JACS Au · 2026
    Article

266 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Deliang ChenKey Laboratory of Organo-Pharmaceutical Chemistry of Jiangxi Province, Chemistry and Chemical Engineering College, Gannan Normal University, Ganzhou, Jiangxi 341000, P. R. China.
Numan OezguenDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Microbiome Center, Texas Children's Hospital, Houston, TX 77030, USA.ORCID 0000-0002-3175-2382
Petri UrvilDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Microbiome Center, Texas Children's Hospital, Houston, TX 77030, USA.ORCID 0000-0003-2516-766X
Colin FergusonEchelon Biosciences Inc., Salt Lake City, UT 84108, USA.ORCID 0000-0002-9021-4533
Sara M DannDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA.
Tor C SavidgeDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Microbiome Center, Texas Children's Hospital, Houston, TX 77030, USA.
Baylor College of Medicine · USEchelon Biosciences · USGannan Normal University · CNThe University of Texas Medical Branch at Galveston · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
Allosteric therapy of the Clostridium difficile toxinsR01AI100914 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SAVIDGE, TOR C. · 2012 to 2016
$1.9M
Metabolome-Based Biomarkers and Neutraceuticals in Clostridium Difficile InfectionR21DK096323 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI SAVIDGE, TOR C. · 2014 to 2015
$433k
UTMB Clinical and Translational Science AwardKL2TR000072 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$422k
NCATS NIH HHS KL2 TR000072NCATS NIH HHS UL1 TR0000711NIAID NIH HHS R01 AI100914NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R21 DK096323
6 · The paper itself

Abstract

Hydrogen (H)-bonds potentiate diverse cellular functions by facilitating molecular interactions. The mechanism and the extent to which H-bonds regulate molecular interactions are a largely unresolved problem in biology because the H-bonding process continuously competes with bulk water. This interference may significantly alter our understanding of molecular function, for example, in the elucidation of the origin of enzymatic catalytic power. We advance this concept by showing that H-bonds regulate molecular interactions via a hitherto unappreciated donor-acceptor pairing mechanism that minimizes competition with water. On the basis of theoretical and experimental correlations between H-bond pairings and their effects on ligand binding affinity, we demonstrate that H-bonds enhance receptor-ligand interactions when both the donor and acceptor have either significantly stronger or significantly weaker H-bonding capabilities than the hydrogen and oxygen atoms in water. By contrast, mixed strong-weak H-bond pairings decrease ligand binding affinity due to interference with bulk water, offering mechanistic insight into why indiscriminate strengthening of receptor-ligand H-bonds correlates poorly with experimental binding affinity. Further support for the H-bond pairing principle is provided by the discovery and optimization of lead compounds targeting dietary melamine and Clostridium difficile toxins, which are not realized by traditional drug design methods. Synergistic H-bond pairings have therefore evolved in the natural design of high-affinity binding and provide a new conceptual framework to evaluate the H-bonding process in biological systems. Our findings may also guide wider applications of competing H-bond pairings in lead compound design and in determining the origin of enzymatic catalytic power.

Indexed as

Hydrogen BondingLigandsDrug DesignModels, ChemicalModels, MolecularMolecular StructureProtein BindingProteinsLigandsProteinsBinding affinityBiological activityClostridium difficile toxinComputational chemistryDrug designEnzyme catalysisHydrogen bonding capabilityHydrogen bond pairingHydrogen bonds

Identifiers

PMID27051863
PMCPMC4820369
OpenAlexW2307778533

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.